Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Inhibitory Activity Assay from US Patent US20240270713: "NOVEL COMPOUND EXHIBITING THERAPEUTIC EFFECT ON INFLAMMATORY DISEASE AS P38 MAP KINASE INHIBITOR"
Assay data:5 Active, 5 Activity ≤ 1 µM, 5 Tested
SummaryRelated BioAssays by Target
Selectivity interaction (Kinase panel (KiNativ target engagement assay in Jurkat cells)) EUB0001635a MAPK14
Assay data:1 Tested
Selectivity interaction (Kinase panel (KiNativ target engagement assay in Jurkat cells)) EUB0001635a MAPK13
Selectivity interaction (Kinase panel (KiNativ target engagement assay in Jurkat cells)) EUB0001635a MAPK11
Selectivity interaction (Kinase panel (Z-LYTE Assay)) EUB0001632a MAPK14
Selectivity interaction (Kinase panel (Z-LYTE Assay)) EUB0001632a MAPK13
Selectivity interaction (Kinase panel (Z-LYTE Assay)) EUB0001632a MAPK12
Selectivity interaction (Kinase panel (Z-LYTE Assay)) EUB0001632a MAPK11
Selectivity interaction (KinomeScan (DiscoverX)) EUB0001326b MAPK14
Selectivity interaction (Radiometric kinase assay) EUB0001326b MAPK14
Selectivity interaction (Radiometric kinase assay) EUB0001326b MAPK13
Selectivity interaction (KinomeScan (DiscoverX)) EUB0001326b MAPK13
Selectivity interaction (Radiometric kinase assay) EUB0001326b MAPK12
Selectivity interaction (KinomeScan (DiscoverX)) EUB0001326b MAPK12
Selectivity interaction (KinomeScan (DiscoverX)) EUB0001326b MAPK11
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on